Text Size

Reperfusion Time in ST Segment Elevation Myocardial Infarction (STEMI)

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT00497419
First received: July 5, 2007
Last updated: August 19, 2008
Last verified: August 2008
History of Changes
  Purpose

Reperfusion delay in STEMI has been shown to be excessive in our community. In order to improve delay a fast track (direct transfer in catheterization laboratory) has been implemented. The present study aims at evaluating the benefits of this procedure.


Condition Intervention
Myocardial Infarction
 Procedure: fast track

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Evaluation of a Fast Track for Patients With STEMI

Resource links provided by NLM:

MedlinePlus related topics: Heart Attack
U.S. FDA Resources

Further study details as provided by University Hospital, Geneva:

Primary Outcome Measures:
  • Door to balloon time [ Time Frame: one year ]

Estimated Enrollment: 150
Study Start Date: January 2007
Study Completion Date: October 2007
Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
Detailed Description:

Reperfusion delay in STEMI has been shown to be excessive in our community. Admission in emergency room and waiting for transfer to catheterization laboratory seems to be the principal source of delay. In order to improve delays a fast track (direct transfer in catheterization laboratory) has been implemented for patients being diagnosed with STEMI by emergency physician out of hospital. The present study aims at evaluating the benefits of this procedure.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of STEMI

Exclusion Criteria:

  • On site resuscitated patients
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00497419

Locations
Switzerland
Geneva University Hospital, Emergency Service
Geneva, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Principal Investigator: Olivier Grosgurin, MD Geneva University Hospital
  More Information

No publications provided by University Hospital, Geneva

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT00497419     History of Changes
Other Study ID Numbers: 06199
Study First Received: July 5, 2007
Last Updated: August 19, 2008
Health Authority: Switzerland: Ethikkommission

Keywords provided by University Hospital, Geneva:
STEMI
ST elevation myocardial infarction

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
 Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on June 18, 2013